Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

被引:31
|
作者
Khaleva, Ekaterina [1 ]
Rattu, Anna [1 ]
Brightling, Chris [2 ]
Bush, Andrew [3 ,4 ]
Bossios, Apostolos [5 ,6 ]
Bourdin, Arnaud [7 ]
Chung, Kian Fan [8 ]
Chaudhuri, Rekha [9 ]
Coleman, Courtney [10 ]
Dahlen, Sven-Erik [5 ,6 ]
Djukanovic, Ratko [1 ,11 ]
Deschildre, Antoine [12 ,13 ]
Fleming, Louise [8 ]
Fowler, Stephen J. [14 ]
Gupta, Atul [15 ]
Hamelmann, Eckard [16 ]
Hashimoto, Simone [17 ,18 ]
Hedlin, Gunilla [19 ,20 ]
Koppelman, Gerard H. [21 ,22 ]
Melen, Erik [23 ]
Murray, Clare S. [14 ]
Pilette, Charles [24 ,25 ]
Porsbjerg, Celeste [26 ]
Pike, Katharine C. [27 ]
Rusconi, Franca [28 ]
Williams, Clare
Ahrens, Birgit [29 ]
Alter, Peter [30 ]
Anckers, Freja [31 ]
van den Berge, Maarten [32 ]
Blumchen, Katharina [33 ]
Brusselle, Guy [34 ]
Clarke, Graham W. [35 ]
Cunoosamy, Danen [36 ]
Dahlen, Barbro [5 ,6 ]
Dixey, Piers [8 ,37 ]
Exley, Andrew [38 ]
Frey, Urs [39 ]
Gaillard, Erol A. [40 ]
Giovannini-Chami, Lisa [41 ,42 ]
Grigg, Jonathan [43 ]
Hartenstein, Diana [29 ]
Heaney, Liam G. [44 ]
Karadag, Bulent [45 ]
Kaul, Susanne [29 ]
Kull, Inger [23 ]
Licari, Amelia [46 ]
Maitland-van der Zee, Anke H. [17 ,18 ]
Mahler, Vera [29 ]
Schoos, Ann-Marie M. [47 ,48 ]
机构
[1] Univ Southampton, Clin & Expt Sci & Human Dev & Hlth, Fac Med, Southampton, Hants, England
[2] Univ Leicester, Inst Lung Hlth, Leicester NIHR Biomed Res Ctr, Leicester, Leics, England
[3] Imperial Coll, Royal Brompton Hosp, Ctr Paediat & Child Hlth, London, England
[4] Imperial Coll, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[5] Karolinska Inst, Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden
[6] Karolinska Inst, Dept Med, Stockholm, Sweden
[7] Univ Montpellier, PhyMedExp, Montpellier, France
[8] Imperial Coll London, Natl Heart & Lung Inst, London, England
[9] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[10] European Lung Fdn, Sheffield, S Yorkshire, England
[11] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England
[12] CHU Lille, Unite Pneumol & Allergol Pediat, Hop Jeanne Flandre, Lille, France
[13] Univ Lille, U1019, UMR 8204, CIIL, Lille, France
[14] Univ Manchester, Manchester Univ NHS Fdn Trust, Sch Biol Sci, Div Infect Immun & Resp Med,Fac Biol Med & Hlth,N, Manchester, Lancs, England
[15] Kings Coll Hosp London, Dept Paediat Resp Med, London, England
[16] Univ Bielefeld, Dept Pediat, Childrens Ctr Bethel, Bielefeld, Germany
[17] Amsterdam UMC Locat Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Resp Med & Allergy, Amsterdam, Netherlands
[18] Univ Amsterdam, Amsterdam UMC, Dept Resp Med, Amsterdam, Netherlands
[19] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
[20] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden
[21] Univ Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Univ Med Ctr Groningen, Groningen, Netherlands
[22] Univ Groningen, Groningen Res Inst Asthma & COPD GRIAC, Univ Med Ctr Groningen, Groningen, Netherlands
[23] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden
[24] UCLouvain, Inst Expt Clin Res IREC, Dept Pulmonol, Clin Univ St Luc, Brussels, Belgium
[25] UCLouvain, Inst Expt & Clin Res IREC, Pole Pulmonol ENT & Dermatol, Brussels, Belgium
[26] Bispebjerg Hosp, Resp Res Unit, Dept Resp Med, Copenhagen, Denmark
[27] Bristol Royal Hosp Children, Dept Paediat Resp Med, Bristol, Avon, England
[28] Azienda USL Toscana Nord Ovest, Dept Mother & Child Hlth, Pisa, Italy
[29] Fed Inst Vaccines & Biomed, Div Allergol, Paul Ehrlich Inst, Langen, Germany
[30] Philipps Univ Marburg UMR, Dept Med Pulm & Crit Care Med, Marburg, Germany
[31] 3TR Resp Patient Working Grp, Brussels, Belgium
[32] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands
[33] Goethe Univ, Univ Hosp Frankfurt, Div Pneumol, Dept Children & Adolescent Med,Allergol,Cyst Fibr, Frankfurt, Germany
[34] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium
[35] AstraZeneca, Res & Early Dev, Resp & Immunol, BioPharmaceut R&D,Translat Sci & Expt Med, Gothenburg, Sweden
[36] Sanofi Genzyme, Global Med Affairs Resp Allergy & GI, Cambridge, MA USA
[37] Royal Brompton Hosp, London, England
[38] Adept Biol Consulting Ltd, London, England
[39] Univ Basel, Univ Childrens Hosp Basel, Basel, Switzerland
[40] Univ Leicester, Leicester NIHR Biomed Res Ctr Resp Theme, Dept Resp Sci, Leicester, Leics, England
[41] Hop Pediat Nice CHU Lenval, Pediat Pulmonol & Allergol Dept, Nice, France
[42] Univ Cote dAzur, Nice, France
[43] Queen Mary Univ London, Blizard Inst, Ctr Genom & Child Hlth, London, England
[44] Queens Univ Belfast, Wellcome Wolfson Ctr Expt Med, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland
[45] Marmara Univ, Fac Med, Div Pediat Pulmonol, Istanbul, Turkiye
[46] Univ Pavia, Pediat Clin, Fdn IRCCS Policlin San Matteo, Pavia, Italy
[47] Univ Copenhagen, Herlev & Gentofte Hosp, COpenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark
[48] Slagelse Sygehus, Dept Pediat, Slagelse, Denmark
[49] Birmingham Childrens Hosp, Dept Resp Med, Birmingham, W Midlands, England
[50] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England
关键词
QUALITY-OF-LIFE; CONTROL QUESTIONNAIRE; SYSTEMATIC REVIEWS; DIFFICULT ASTHMA; VALIDATION; CHILDREN; BURDEN; IMPAIRMENT; GUIDELINES; CHILDHOOD;
D O I
10.1183/13993003.00606-2022
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) Working Group sought to develop Core Outcome Measures (COM) sets to facilitate better synthesis of data and appraisal of biologics in paediatric and adult asthma clinical studies. Methods COMSA utilised a multi-stakeholder consensus process among patients with severe asthma, adult and paediatric clinicians, pharmaceutical representatives, and health regulators from across Europe. Evidence included a systematic review of development, validity and reliability of selected outcome measures plus a narrative review and a pan-European survey to better understand patients' and carers' views about outcome measures. It was discussed using a modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision framework. Anonymous voting was conducted using predefined consensus criteria. Results Both adult and paediatric COM sets include forced expiratory volume in 1 s (FEV1) as z-scores, annual frequency of severe exacerbations and maintenance oral corticosteroid use. Additionally, the paediatric COM set includes the Paediatric Asthma Quality of Life Questionnaire and Asthma Control Test or Childhood Asthma Control Test, while the adult COM set includes the Severe Asthma Questionnaire and Asthma Control Questionnaire-6 (symptoms and rescue medication use reported separately). Conclusions This patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Development and Implementation of Core Outcome Measures sets for Severe Asthma in Paediatric Patients
    Roberts, G.
    ALLERGOLOGIE, 2024, 47 (06)
  • [2] Core outcome sets and core outcome measures: a primer
    Alam, Murad
    Ibrahim, Sarah A.
    Kang, Bianca Y.
    Yanes, Arianna F.
    Mittal, Bharat B.
    Schlessinger, Daniel I.
    Zloty, David
    Poon, Emily
    Lee, Erica H.
    Sobanko, Joseph F.
    Lawrence, Naomi
    Behshad, Ramona
    Maher, Ian A.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022, 314 (04) : 389 - 391
  • [3] Core outcome sets and core outcome measures: a primer
    Murad Alam
    Sarah A. Ibrahim
    Bianca Y. Kang
    Arianna F. Yanes
    Bharat B. Mittal
    Daniel I. Schlessinger
    David Zloty
    Emily Poon
    Erica H. Lee
    Joseph F. Sobanko
    Naomi Lawrence
    Ramona Behshad
    Ian A. Maher
    Archives of Dermatological Research, 2022, 314 : 389 - 391
  • [4] Developing Core Outcome Sets (COS) and Core Outcome Measures Sets (COMS) in Cosmetic Gynecological Interventions: Protocol for a Development and Usability Study
    Doumouchtsis, Stergios K.
    Nama, Vivek
    Falconi, Gabriele
    Rada, Maria Patricia
    Manonai, Jittima
    Iancu, George
    Haddad, Jorge Milhem
    Betschart, Cornelia
    JMIR RESEARCH PROTOCOLS, 2021, 10 (11):
  • [5] Are core data sets the answer for outcome measures?
    Oeffinger, Donna
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2017, 59 (03): : 244 - 244
  • [6] Variability of outcome measures in trials of intravenous therapy in acute severe paediatric asthma: a systematic review
    Gray, Charmaine S.
    Powell, Colin V. E.
    Babl, Franz E.
    Dalziel, Stuart R.
    Craig, Simon
    EMERGENCY MEDICINE JOURNAL, 2019, 36 (04) : 225 - 230
  • [7] Acute severe paediatric asthma: study protocol for the development of a core outcome set, a Pediatric Emergency Research Networks (PERN) study
    Simon Craig
    Franz E. Babl
    Stuart R. Dalziel
    Charmaine Gray
    Colin Powell
    Khalid Al Ansari
    Mark D. Lyttle
    Damian Roland
    Javier Benito
    Roberto Velasco
    Julia Hoeffe
    Diana Moldovan
    Graham Thompson
    Suzanne Schuh
    Joseph J. Zorc
    Maria Kwok
    Prashant Mahajan
    Michael D. Johnson
    Robert Sapien
    Kajal Khanna
    Pedro Rino
    Javier Prego
    Adriana Yock
    Ricardo M. Fernandes
    Indumathy Santhanam
    Baljit Cheema
    Gene Ong
    Shu-Ling Chong
    Andis Graudins
    Trials, 21
  • [8] Acute severe paediatric asthma: study protocol for the development of a core outcome set, a Pediatric Emergency Reserarch Networks (PERN) study
    Craig, Simon
    Babl, Franz E.
    Dalziel, Stuart R.
    Gray, Charmaine
    Powell, Colin
    Al Ansari, Khalid
    Lyttle, Mark D.
    Roland, Damian
    Benito, Javier
    Velasco, Roberto
    Hoeffe, Julia
    Moldovan, Diana
    Thompson, Graham
    Schuh, Suzanne
    Zorc, Joseph J.
    Kwok, Maria
    Mahajan, Prashant
    Johnson, Michael D.
    Sapien, Robert
    Khanna, Kajal
    Rino, Pedro
    Prego, Javier
    Yock, Adriana
    Fernandes, Ricardo M.
    Santhanam, Indumathy
    Cheema, Baljit
    Ong, Gene
    Chong, Shu-Ling
    Graudins, Andis
    TRIALS, 2020, 21 (01)
  • [9] Core outcome sets (COS) and the core outcome measures in effectiveness trials (COMET) initiative: patient participation in COS development
    Williamson, Paula
    Gargon, Elizabeth
    Gorst, Sarah
    Altman, Doug
    Blazeby, Jane
    Clarke, Mike
    Tunis, Sean
    QUALITY OF LIFE RESEARCH, 2016, 25 : 68 - 68
  • [10] Uptake of core outcome sets in paediatric clinical trials: a protocol
    Lei, Ruobing
    Estill, Janne
    Florez, Ivan D.
    Li, Qiu
    Chen, Yaolong
    Williamson, Paula
    BMJ PAEDIATRICS OPEN, 2025, 9 (01)